1. Home
  2. VYNE vs ARTW Comparison

VYNE vs ARTW Comparison

Compare VYNE & ARTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYNE
  • ARTW
  • Stock Information
  • Founded
  • VYNE 2003
  • ARTW 1956
  • Country
  • VYNE United States
  • ARTW United States
  • Employees
  • VYNE N/A
  • ARTW N/A
  • Industry
  • VYNE Biotechnology: Pharmaceutical Preparations
  • ARTW Industrial Machinery/Components
  • Sector
  • VYNE Health Care
  • ARTW Industrials
  • Exchange
  • VYNE Nasdaq
  • ARTW Nasdaq
  • Market Cap
  • VYNE 12.3M
  • ARTW 12.5M
  • IPO Year
  • VYNE 2018
  • ARTW N/A
  • Fundamental
  • Price
  • VYNE $0.38
  • ARTW $2.16
  • Analyst Decision
  • VYNE Buy
  • ARTW
  • Analyst Count
  • VYNE 2
  • ARTW 0
  • Target Price
  • VYNE $8.00
  • ARTW N/A
  • AVG Volume (30 Days)
  • VYNE 1.7M
  • ARTW 60.3K
  • Earning Date
  • VYNE 11-06-2025
  • ARTW 10-07-2025
  • Dividend Yield
  • VYNE N/A
  • ARTW N/A
  • EPS Growth
  • VYNE N/A
  • ARTW N/A
  • EPS
  • VYNE N/A
  • ARTW 0.49
  • Revenue
  • VYNE $524,000.00
  • ARTW $24,079,949.00
  • Revenue This Year
  • VYNE N/A
  • ARTW N/A
  • Revenue Next Year
  • VYNE N/A
  • ARTW N/A
  • P/E Ratio
  • VYNE N/A
  • ARTW $5.56
  • Revenue Growth
  • VYNE 6.29
  • ARTW N/A
  • 52 Week Low
  • VYNE $0.28
  • ARTW $1.43
  • 52 Week High
  • VYNE $4.30
  • ARTW $4.71
  • Technical
  • Relative Strength Index (RSI)
  • VYNE 55.03
  • ARTW 37.57
  • Support Level
  • VYNE $0.35
  • ARTW $2.23
  • Resistance Level
  • VYNE $0.40
  • ARTW $2.47
  • Average True Range (ATR)
  • VYNE 0.03
  • ARTW 0.14
  • MACD
  • VYNE 0.00
  • ARTW -0.01
  • Stochastic Oscillator
  • VYNE 74.75
  • ARTW 9.80

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

About ARTW Art's-Way Manufacturing Co. Inc.

Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.

Share on Social Networks: